News
Bayer Leverkusen have made an audacious move to sign Barcelona midfielder Marc Casado. According to Fichajes, the German club ...
According to transfer journalists Florian Plettenberg, Fabrizio Romano, and Sacha Tavolieri, who all report in agreement, the ...
21h
Zacks Investment Research on MSNBayer Gets FDA Nod for Label Expansion of Kerendia in Heart FailureBayer AG BAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The ...
Approval of Kerendia was based on results from the Phase III FINEARTS-HF trial, which demonstrated statistically significant ...
The US regulator has cleared use of Kerendia (finerenone) for the treatment of heart failure patients who have a left ...
Bayer Leverkusen has moved to replace Florian Wirtz by signing United States international Malik Tillman from PSV Eindhoven ...
3don MSN
The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...
The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...
My emails exploded with support’: senior VP of HR discusses authenticity in leadership, along with celebrating DEI and ...
While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...
6d
Zacks Investment Research on MSNBayer Begins Phase I/II Study on Cell Therapy for Eye DiseaseBayer’s BAYRY wholly owned subsidiary, BlueRock Therapeutics, announced that the first patient in the phase I/IIa CLARICO ...
A long-time Bayer employee with diverse financial experience is taking on a new challenge at the helm of the company's North ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results